CONMED Corporation CNMD
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 19.80M | 23.07M | 13.83M | 16.74M | 2.86M |
| Total Depreciation and Amortization | 19.18M | 19.05M | 18.84M | 17.65M | 18.61M |
| Total Amortization of Deferred Charges | 610.00K | 1.05M | 1.28M | 2.74M | 1.28M |
| Total Other Non-Cash Items | 10.80M | 5.07M | 3.84M | 25.23M | 9.61M |
| Change in Net Operating Assets | -980.00K | -11.15M | -24.31M | -16.02M | 21.33M |
| Cash from Operations | 49.41M | 37.10M | 13.47M | 46.34M | 53.69M |
| Capital Expenditure | -2.68M | -2.93M | -2.89M | -5.11M | -5.19M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 813.00K | 14.50M | 7.00M | -- | -- |
| Other Investing Activities | -- | -- | -- | -2.00M | 0.00 |
| Cash from Investing | -1.87M | 11.57M | 4.11M | -7.11M | -5.19M |
| Total Debt Issued | 168.00M | 865.00M | 180.00M | 187.00M | 167.00M |
| Total Debt Repaid | -186.63M | -884.18M | -155.00M | -207.00M | -196.00M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -6.20M | -6.20M | -37.02M | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -6.19M | -6.19M |
| Other Financing Activities | -12.13M | -20.85M | -10.54M | -11.18M | -8.34M |
| Cash from Financing | -36.96M | -46.23M | -22.55M | -37.37M | -43.53M |
| Foreign Exchange rate Adjustments | 61.00K | -129.00K | -814.00K | 34.00K | 20.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.64M | 2.30M | -5.79M | 1.89M | 4.99M |